Prometheus, Tarrot to Seek Crohn's Disease Biomarkers for PGx Applications

The companies aim to identify genetic and serologic biomarkers for use in predicting response to treatments such as Cimzia, Humira, and Remicade, and to develop diagnostics based on the biomarkers.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories